Search - tctmd.com

Displaying 1 - 20 of 165

Sort: Relevancy | Date

Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator

Presentation TCT 2016

Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator

Presenter: Emerson C. Perin, Mark W.I. Webster

November 01, 2016

News Features

Future of Renal Denervation May Hinge on a Handful of Small Studies

February 14, 2016

News Daily News

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

January 19, 2016

News Industry News

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

January 05, 2016

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

Presentation TCT 2015

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis

October 13, 2015

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

Presentation TCT 2015

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen

October 13, 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presentation TCT 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder

October 13, 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presentation TCT 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presenter: Michael A. Weber, Stephen G. Worthley

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

News Conference News TCT 2015

SYMPLICITY HTN-3 Results Continue to Spur Discussion

October 11, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

News Conference News ACC 2015

Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension

March 17, 2015

News Daily News

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

February 03, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

January 12, 2015

News Daily News

研究表明肾神经去除术并不比强化药物治疗更有效

December 10, 2014

News Daily News

Un Estudio Sugiere que la Denervación Renal No es Más Eficaz que un Tratamiento Farmacológico Intensificado

December 10, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.